🕵️ ESSA Pharma Inc. ($EPIX)

SEC insider & ownership activity, last 12 months · CIK 1633932 · every row links its SEC filing

Insiders were quiet over the last 12 months – no open-market buys or sells. Soleus Capital Master Fund, L.P. added 5.1% → 9.8%. One red-flag 8-K in the window: Delisting notice (3.01), Oct 9, 2025.

Insider flow

0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
Soleus Capital, LLC 9.8% 13DJul 17, 2025 filing ↗
Soleus Capital Group, LLC 9.8% 13DJul 17, 2025 filing ↗
Soleus Capital Management, L.P. 9.8% 13DJul 17, 2025 filing ↗
Soleus GP, LLC 9.8% 13DJul 17, 2025 filing ↗
Guy Levy 9.8% 13DJul 17, 2025 filing ↗
Soleus Capital Master Fund, L.P. 9.8% 13DJul 17, 2025 filing ↗
BML Investment Partners, L.P. 9.5% 13DApr 24, 2025 filing ↗
Soleus Capital Master Fund, L.P. 5.1% 13GFeb 11, 2025 filing ↗
Soleus Capital, LLC 5.1% 13GFeb 11, 2025 filing ↗
Soleus Capital Group, LLC 5.1% 13GFeb 11, 2025 filing ↗
Soleus Capital Management, L.P. 5.1% 13GFeb 11, 2025 filing ↗
Soleus GP LLC 5.1% 13GFeb 11, 2025 filing ↗
Guy Levy 5.1% 13GFeb 11, 2025 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Acquisition or disposition (2.01)Oct 9, 2025 filing ↗
Delisting notice (3.01)Oct 9, 2025 filing ↗
Material Modifications to Rights of Security Holders (3.03)Oct 9, 2025 filing ↗
Change of control (5.01)Oct 9, 2025 filing ↗
Officer/director changes (5.02)Oct 9, 2025 filing ↗
Other events (8.01)Oct 9, 2025 filing ↗
Financial Statements and Exhibits (9.01)Oct 9, 2025 filing ↗
Shareholder vote (5.07)Oct 3, 2025 filing ↗
Other events (8.01)Oct 3, 2025 filing ↗
Financial Statements and Exhibits (9.01)Oct 3, 2025 filing ↗
Other events (8.01)Sep 30, 2025 filing ↗
Other events (8.01)Sep 30, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 30, 2025 filing ↗
Material agreement (1.01)Sep 23, 2025 filing ↗
Other events (8.01)Sep 23, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 23, 2025 filing ↗